Choose another country or region to see content specific to your location and shop online.
En raison des retards de livraison et de la réduction des effectifs chez les transporteurs, les commandes passées après le 16 décembre pourraient arriver le 10 janvier ou après ; les délais de livraison ne sont pas garantis.
Due to health Canada policy this item cannot be returned.
Indications
Local or loco-regional dental anesthesia in patients of at least 4 years old
Features & benefits
Fast onset to avoid delay before effective analgesia is achieved
No-methylparaben formulation to avoid allergic reactions on sensitive patients
Latex-free plungers and seals
High epinephrine concentration to improve blood control on the procedure's site
Terminal sterilization of product/cartridges for safe use
Milar label covered glass cartridges to minimize risk of wound in the event of a cartridge breakage
Presentation
Item #99145: Box containing 50 cartridges x 1.7 ml
Risk information
Septanest
SP is indicated for local, infiltrative, or conductive anesthesia in
both simple and complex dental procedures. Septanest SP with
epinephrine 1:100,000 is preferred during operative or surgical
procedures when improved visualization of the surgical field is
desirable. Reactions to Septanest SP (pain and headache, for example,
or convulsions or respiratory arrest following accidental intravascular
injection) are characteristic of those associated with other amide-type
local anesthetics. Septanest SP contains sodium metabisulfite, a
sulfite that may cause allergic-type reactions including anaphylactic
symptoms and life-threatening or less severe asthmatic episodes in
certain susceptible people. Accidental intravascular injection may be
associated with convulsions, followed by central nervous system or
cardiorespiratory depression and coma, progressing ultimately to
respiratory arrest. Dental practitioners and/or clinicians who employ
local anesthetic agents should be well versed in diagnosis and
management of emergencies that may arise from their use. Resuscitative
equipment, oxygen, and other resuscitative drugs should be available for
immediate use. Septanest SP, along with other local anesthetics, is
capable of producing methemoglobinemia. The clinical signs of
methemoglobinemia are cyanosis of the nail beds and lips, fatigue and
weakness. If methemoglobinemia does not respond to administration of
oxygen, administration of methylene blue intravenously 1-2 mg/kg body
weight over a 5 minute period is recommended. Please see the Package
Insert for prescribing information.
